Assefa Andargie1, Asressie Molla1, Fentaw Tadese1, Segenet Zewdie2. 1. School of Public Health, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia. 2. Department of Pharmacy, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
Abstract
BACKGROUND: One third of global antmicrobial resistance deaths are attributed to drug resistant tuberculosis. Lost to follow-up is one of the causes of the development of acquired drug resistant tuberculosis. There is a gap in nationally representative reliable information on lost to follow-up among patients with drug-resistant tuberculosis in Ethiopia. OBJECTIVE: To estimate the pooled prevalence and associated factors of lost to follow-up among patients with drug resistant tuberculosis in Ethiopia. METHODS: Observational studies searched from PubMed, HINARI and CINAHL were screened for eligibility. After assessing the quality of studies, data were extracted using a checklist. Heterogeneity was assessed using forest plot, Q and I2. The random effects meta-analysis model was employed to pull the prevalence of lost to follow-up. Sub-group analysis and meta regression were performed to identify the sources of heterogeneity. Publication bias was assessed using funnel plots with Egger's and Begg's tests. Sensitivity analysis was performed to assess the influence of individual studies on the overall estimate. The odds ratios were used to measure associations. RESULTS: The review was performed among 11 studies of which 9 were cohort studies. The sample sizes ranged from 90 to 612 and comprised a total of 3,510 participants. The pooled prevalence of lost to follow-up was 8.66% (95% CI, 5.01-13.14) with a high heterogeneity (I2 = 93.49%, p<0.001). Pulmonary multi-drug resistant tuberculosis patients were 50% less likely to loss from follow-up compared to extra pulmonary tuberculosis patients. CONCLUSION: There was a high prevalence of lost to follow-up among multi-drug resistant tuberculosis patients in Ethiopia. Anatomical site of tuberculosis was a significant factor affecting lost to follow-up. Strengthening the health care system and patient education should be given a due emphasis. REGISTRATION NUMBER: CRD42020153326; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=153326.
BACKGROUND: One third of global antmicrobial resistance deaths are attributed to drug resistant tuberculosis. Lost to follow-up is one of the causes of the development of acquired drug resistant tuberculosis. There is a gap in nationally representative reliable information on lost to follow-up among patients with drug-resistant tuberculosis in Ethiopia. OBJECTIVE: To estimate the pooled prevalence and associated factors of lost to follow-up among patients with drug resistant tuberculosis in Ethiopia. METHODS: Observational studies searched from PubMed, HINARI and CINAHL were screened for eligibility. After assessing the quality of studies, data were extracted using a checklist. Heterogeneity was assessed using forest plot, Q and I2. The random effects meta-analysis model was employed to pull the prevalence of lost to follow-up. Sub-group analysis and meta regression were performed to identify the sources of heterogeneity. Publication bias was assessed using funnel plots with Egger's and Begg's tests. Sensitivity analysis was performed to assess the influence of individual studies on the overall estimate. The odds ratios were used to measure associations. RESULTS: The review was performed among 11 studies of which 9 were cohort studies. The sample sizes ranged from 90 to 612 and comprised a total of 3,510 participants. The pooled prevalence of lost to follow-up was 8.66% (95% CI, 5.01-13.14) with a high heterogeneity (I2 = 93.49%, p<0.001). Pulmonary multi-drug resistant tuberculosispatients were 50% less likely to loss from follow-up compared to extra pulmonary tuberculosispatients. CONCLUSION: There was a high prevalence of lost to follow-up among multi-drug resistant tuberculosispatients in Ethiopia. Anatomical site of tuberculosis was a significant factor affecting lost to follow-up. Strengthening the health care system and patient education should be given a due emphasis. REGISTRATION NUMBER: CRD42020153326; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=153326.
Authors: Jan J Barendregt; Suhail A Doi; Yong Yi Lee; Rosana E Norman; Theo Vos Journal: J Epidemiol Community Health Date: 2013-08-20 Impact factor: 3.710
Authors: Kefyalew Addis Alene; Kerri Viney; Emma S McBryde; Adino Tesfahun Tsegaye; Archie C A Clements Journal: Trop Med Int Health Date: 2017-01-06 Impact factor: 2.622
Authors: Habteyes H Tola; Kourosh Holakouie-Naieni; Mohammad A Mansournia; Mehdi Yaseri; Ephrem Tesfaye; Zemedu Mahamed; Million Molla Sisay Journal: Sci Rep Date: 2019-12-27 Impact factor: 4.379
Authors: B Memani; B Beko; N Dumile; E Mohr-Holland; J Daniels; B Sibanda; Z Damse; V Scott; E von der Heyden; C Pfaff; A Reuter; J Furin Journal: Public Health Action Date: 2022-06-21